Fate of ischemic limbs in patients with Buerger's disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?

Surg Today. 2015 Apr;45(4):466-70. doi: 10.1007/s00595-014-0904-6. Epub 2014 Apr 26.

Abstract

Purpose: We herein review the long-term results of our series of critical ischemic limbs caused by Buerger's disease.

Methods: A retrospective review of 103 patients with critical limb ischemia who were diagnosed with Buerger's disease by Shionoya's criteria between 1980 and 2010.

Results: The age of onset was 38.0 ± 9.7 years (mean ± SD). The median follow-up was 97 months. Thirty-three patients had pain at rest, and 65 patients presented with ischemic ulcers in their toes and/or fingers. Gangrene was present in five patients. Sixteen patients achieved remission with medical therapy and smoking cessation. Sixty-six patients underwent sympathectomy. Bypass to the crural arteries was performed in 23 limbs, with assisted primary patency rates of 67.0 and 45.6 % at five and 10 years. Graft failure caused major amputation in two out of 10 smokers, but no limbs were lost among the 12 ex-smokers. Therapeutic angiogenesis using cell transplantation led to improvement in three ex-smokers; however, amputation was unavoidable in the one smoker who was treated. The limb salvage rate at 20 years was 90 % in ex-smokers and 69 % in smokers, which was not significantly different.

Conclusions: This study demonstrated no significant difference in the limb salvage rate between ex-smokers and smokers. Our results do not support any advantageous effect of smoking cessation on the long-term remission in patients with Buerger's disease.

MeSH terms

  • Adult
  • Age of Onset
  • Arteries / surgery
  • Extremities / blood supply*
  • Female
  • Follow-Up Studies
  • Humans
  • Ischemia
  • Limb Salvage / methods*
  • Limb Salvage / statistics & numerical data*
  • Male
  • Middle Aged
  • Remission Induction / methods*
  • Retrospective Studies
  • Smoking / adverse effects
  • Smoking / epidemiology
  • Smoking Cessation*
  • Sympathectomy
  • Thromboangiitis Obliterans / diagnosis
  • Thromboangiitis Obliterans / epidemiology
  • Thromboangiitis Obliterans / physiopathology
  • Thromboangiitis Obliterans / therapy*
  • Time Factors
  • Vascular Patency
  • Vascular Surgical Procedures / methods